Search research articles
Contact Us
Filters
Showing results (311-320 of 360) with videos related to
Page
of 36
Sort By:
Respiration Physiology
|
August 1, 1997
Selective resection of the phrenic nerve roots in rabbits. Part II: Respiratory effects
J P Marie, C Tardif, Y Lerosey, et al.
Presse Medicale (Paris, France : 1983)
|
October 26, 1988
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]
J P Marie, J L Pico, D Chiche, et al.
Calcified Tissue Research
|
August 1, 1976
1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease
A E Fournier, P J Bordier, J Gueris, et al.
The European Journal of Medicine
|
May 1, 1993
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial
J L Pico, J P Marie, D Chiche, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]
G Andreu, M Benbunan, M Boasson, et al.
Annales De Medecine Interne
|
January 1, 1983
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]
M H Horellou, E Baumelou, N Sitbon, et al.
British Journal of Haematology
|
February 5, 1998
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression
O Legrand, J Y Perrot, G Simonin, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|
January 1, 1976
1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease
A E Fournier, P J Bordier, J Gueris, et al.
British Journal of Haematology
|
June 1, 1992
Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells
J P Marie, N A Brophy, M N Ehsan, et al.
Nouvelle Revue Francaise D'Hematologie
|
August 1, 1994
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]
C Cordonnier, G Leverger, B Schlemmer, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 360) with videos related to
Sort By:
Page
of 36
Respiration Physiology
|
August 1, 1997
Selective resection of the phrenic nerve roots in rabbits. Part II: Respiratory effects
J P Marie, C Tardif, Y Lerosey, et al.
Presse Medicale (Paris, France : 1983)
|
October 26, 1988
[Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]
J P Marie, J L Pico, D Chiche, et al.
Calcified Tissue Research
|
August 1, 1976
1alpha-hydroxycholecalciferol and 25-hydroxycholecalciferol in renal bone disease
A E Fournier, P J Bordier, J Gueris, et al.
The European Journal of Medicine
|
May 1, 1993
Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial
J L Pico, J P Marie, D Chiche, et al.
Nouvelle Revue Francaise D'Hematologie
|
January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]
G Andreu, M Benbunan, M Boasson, et al.
Annales De Medecine Interne
|
January 1, 1983
[4 cases of acquired Willebrand factor deficiency associated with monoclonal dysglobulinemia]
M H Horellou, E Baumelou, N Sitbon, et al.
British Journal of Haematology
|
February 5, 1998
Adult biphenotypic acute leukaemia: an entity with poor prognosis which is related to unfavourable cytogenetics and P-glycoprotein over-expression
O Legrand, J Y Perrot, G Simonin, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association
|
January 1, 1976
1 alpha hydroxycholecalciferol and 25 hydroxycholecalciferol in renal bone disease
A E Fournier, P J Bordier, J Gueris, et al.
British Journal of Haematology
|
June 1, 1992
Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells
J P Marie, N A Brophy, M N Ehsan, et al.
Nouvelle Revue Francaise D'Hematologie
|
August 1, 1994
[Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]
C Cordonnier, G Leverger, B Schlemmer, et al.
Page
of 36